BriaCell Therapeutics
CVE:BCTBriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Dynex Power
CVE:DNXDynex Power Inc., through its subsidiary, Dynex Semiconductor Limited, designs, manufactures, and sells industrial power equipment worldwide. The company's products include high power bipolar discrete semiconductors, high power insulated gate bipolar transistor modules and dies, and high power electronic assemblies and components. Its products are used by electronic equipment manufacturers and maintenance providers in various sectors, including railway propulsion and on-board systems; industrial electric power transmission and distribution, renewable and distributed power, heavy industries, and factory automation; marine propulsion and on-board systems; aircraft power electronic systems; and electric vehicles. The company was founded in 1956 and is based in Kanata, Canada. Dynex Power Inc. is a subsidiary of Zhuzhou CRRC Times Electric Co., Ltd.
FAST Acquisition
NYSE:FSTFAST Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in restaurant, hospitality, and related sectors. FAST Acquisition Corp. was incorporated in 2020 and is based in Ridgefield, Connecticut.